首页> Cancer research communications> Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Funda,Meric-Bernstam

第一单位： Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

作者： Funda,Meric-Bernstam ^[1] ; Martin,Gutierrez ^[2] ; Enrique,Sanz-Garcia ^[3] ; Diego,Villa ^[4] ; Jun,Zhang ^[5] ; Jennifer,Friedmann ^[6] ; Fengting,Yan ^[7] ; Mark A,Socinski ^[8] ; John,Sarantopoulos ^[9] ; Luis E,Raez ^[10] ; Quincy S,Chu ^[11] ; Maxime,Chénard-Poirier ^[12] ; Manash S,Chatterjee ^[13] ; Hong,Ren ^[13] ; Qi,Liu ^[13] ; Douglas A,Levine ^[13] ; Komal L,Jhaveri ^[14]

作者单位： Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] Hackensack University Medical Center, Hackensack, New Jersey. ^[2] Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. ^[3] University of British Columbia, BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada. ^[4] Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.;Division of Medical Oncology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas. ^[5] Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Canada. ^[6] Swedish Cancer Institute, Seattle, Washington. ^[7] AdventHealth Cancer Institute, Orlando, Florida. ^[8] Institute for Drug Development, Mays Cancer Center at University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, Texas. ^[9] Memorial Cancer Institute/Florida Atlantic University (FAU), Miami, Florida. ^[10] Division of Medical Oncology, Department of Oncology, Cross Cancer Institute, Edmonton, Canada. ^[11] CHU de Québec-Université Laval, Québec, Canada. ^[12] Merck & Co., Inc., Rahway, New Jersey. ^[13] Memorial Sloan Kettering Cancer Center, New York, New York.;Weill Cornell Medical College, New York, New York. ^[14]

医学主题词人类(Humans);女(雌)性(Female);中年人(Middle Aged);老年人(Aged);男(雄)性(Male);成年人(Adult);免疫轭合物(Immunoconjugates);受体酪氨酸激酶样孤儿受体(Receptor Tyrosine Kinase-like Orphan Receptors);肿瘤转移(Neoplasm Metastasis);老年人, 80以上(Aged, 80 and over);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);卵巢肿瘤(Ovarian Neoplasms);胰腺肿瘤(Pancreatic Neoplasms)

DOI 10.1158/2767-9764.CRC-25-0019

PMID 40762544

发布时间 2025-09-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer research communications

2025年5卷9期

1664-1673页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer research communications

2025年5卷9期

1664-1673页

检索历史清除

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

检索历史清除